Elevated TIGIT expression may contribute to an immunosuppressive tumor microenvironment by interacting with its ligands (e.g., PVR, NECTIN-2) expressed by stromal and malignant cells, thereby promoting T cell exhaustion and enabling tumor immune evasion. The gene discussed is TIGIT; the disease is neoplasm.